Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients
Clinical trial NCT07560475 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07560475
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-10
- Primary completion
- 2028-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.